Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Barbara Côrrea Krug"'
Autor:
Gabriela Berlanda, Gabriela H. Telo, Barbara Côrrea Krug, Rafael Selbach Scheffel, Bruna Pasinato, Fernando Iorra, João Gabbardo dos Reis, Paulo Dornelles Picon, Beatriz D. Schaan
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 65, Iss 1, Pp 117-119 (2020)
ABSTRACT This is a retrospective report of the frequency of severe hypoglycemia and the association between common mental disorders and type 1 diabetes mellitus treated with insulin analogues. Patients with severe hypoglycemia compared with those wit
Externí odkaz:
https://doaj.org/article/08bed21b56944f51b0555ab101d8cdb2
Autor:
Brígida Dias Fernandes, Bárbara Corrêa Krug, Fernanda D’Athayde Rodrigues, Hérica Núbia Cardoso Cirilo, Stéfani Sousa Borges, Ida Vanessa D. Schwartz, Livia Fernandes Probst, Ivan Zimmermann
Publikováno v:
PLoS ONE, Vol 19, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/bd7dc7dad4b24480ab3e715e154f7326
Autor:
Brígida Dias Fernandes, Bárbara Corrêa Krug, Fernanda D'Athayde Rodrigues, Hérica Núbia Cardoso Cirilo, Stéfani Sousa Borges, Ida Vanessa D Schwartz, Livia Fernandes Probst, Ivan Zimmermann
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0302860 (2024)
BackgroundOnasemnogene abeparvovec has been approved for the treatment of spinal muscular atrophy 5q type 1 in several countries, which calls for an independent assessment of the evidence regarding efficacy and safety.ObjectiveConduct a meta-analysis
Externí odkaz:
https://doaj.org/article/15fa28f86e5e45b480f1fa17cee256b9
Autor:
Fernanda d Athayde Rodrigues, Hérica Nubia Cardoso Cirilo, Stéfani Sousa Borges, Brígida Dias Fernandes, Bárbara Corrêa Krug, Lívia Fernandes Probst, Ivan Ricardo Zimmermann
Publikováno v:
Jornal de Assistência Farmacêutica e Farmacoeconomia, Vol 8, Iss s. 2 (2023)
Introdução: O desenvolvimento de tecnologias inovadoras para o tratamento da Atrofia Muscular Espinhal (AME) tipo 1 tem se mostrado promissor na mudança da morbimortalidade dos pacientes com essa condição. No entanto, o alto custo das terapias e
Externí odkaz:
https://doaj.org/article/80302f501d824bb4a604f6729bf0089e
Autor:
Stéfani Sousa Borges, Brígida Dias Fernandes, Bárbara Corrêa Krug, Fernanda d’Athayde Rodrigues, Hérica Núbia Cardoso Cirilo, Livia Fernandes Probst, Ivan Ricardo Zimmermann
Publikováno v:
Jornal de Assistência Farmacêutica e Farmacoeconomia, Vol 7, Iss 4 (2023)
Objetivo: Foram avaliadas evidências de eficácia e segurança do onasemnogeno abeparvoveque no tratamento da atrofia muscular espinhal tipo 1. Método: Foi conduzida uma revisão sistemática da literatura, conforme protocolo aprovado previamente.
Externí odkaz:
https://doaj.org/article/bc0485d1e787440c9a4ec3946baae6f0
Autor:
Stéfani Sousa Borges, Brígida Dias Fernandes, Bárbara Corrêa Krug, Fernanda D’Athayde Rodrigues, Hérica Núbia Cardoso Cirilo, Livia Fernandes Probst, Ivan Zimmermann
Publikováno v:
Jornal de Assistência Farmacêutica e Farmacoeconomia, Vol 7, Iss s.1 (2023)
Introdução: A atrofia muscular espinhal 5q (AME) é uma doença genética rara, caracterizada por uma progressiva perda de força muscular decorrente da degeneração de neurônios da medula espinhal. A AME tipo I corresponde a aproximadamente 58%
Externí odkaz:
https://doaj.org/article/a82f373370354cad8867049695abd9a3
Autor:
Gabriela Berlanda, Gabriela H. Telo, Bárbara Côrrea Krug, Rafael Selbach Scheffel, Bruna Pasinato, Fernando Iorra, João Gabbardo dos Reis, Paulo Dornelles Picon, Beatriz D. Schaan
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 65, Iss 2, Pp 164-171 (2021)
ABSTRACT Objective: The aim of this study was to evaluate the frequency of hypoglycemia and the treatment satisfaction in patients with type 1 diabetes (T1D) using insulin analogues. Subjects and methods: This observational retrospective study includ
Externí odkaz:
https://doaj.org/article/4fbda34677584126bb201f10f453d9f7
Autor:
Tatiane Alves Vieira, Tatiéle Nalin, Bárbara Correa Krug, Camila Matzenbacher Bittar, Cristina Brinckmann Oliveira Netto, Ida Vanessa Doederlein Schwartz
Publikováno v:
Journal of Inborn Errors of Metabolism and Screening, Vol 3 (2015)
Introduction: Phenylketonuria (PKU) is caused by the deficient activity of phenylalanine hydroxylase. Aim: To identify the factors associated with treatment adherence among patients with PKU seen at a southern Brazil reference center. Methodology: A
Externí odkaz:
https://doaj.org/article/9499c25a43b243db8bce005fb204f366